Work

An Immunoglobulin Fusion Protein Based on the gp120-CD4 Receptor Complex Potently Inhibits Human Immunodeficiency Virus Type 1 in Vitro

Year: 2006

Type: article

Source: AIDS Research and Human Retroviruses

DOI: 10.1089/aid.2006.22.477

Authors: John R. Vu, Timothy Fouts, Katherine Bobb, Jennifer Burns, Brenda McDermott, David I. Israel, Karla Godfrey, Anthony DeVico

Institutions: University of Maryland, Baltimore, Profectus Biosciences (United States), TetraLogic Pharmaceuticals (United States)

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases

Awards: Immunity and Infection, HIV-1 PASSIVE IMMUNITY AGAINST CORECEPTOR INTERACTIONS, NOVEL HIV VACCINES

OpenAlex ID: W2015622018

FWCI: 0.462

Cites: 100

Cited by: 13

Related to: 10